Abstract:Introduction Recombination serves as a common strategy employed by RNA viruses for their genetic evolution. Extensive genomic surveillance during the COVID-19 pandemic has reported SARS-CoV-2 Recombinant strains indicating recombination events during the viral evolution. This study introspects the phenomenon of genome recombination by tracing the footprint of prominent lineages of SARS-CoV-2 at different time points in the context of on-going evolution and emergence of Recombinants. Method Whole genome sequencing was carried out for 2,516 SARS-CoV-2 (discovery cohort) and 1,126 (validation cohort) using nasopharyngeal samples collected between the time period of March 2020 to August 2022, as part of the genomic surveillance program. The sequences were classified according to the different lineages of SARS-CoV-2 prevailing in India at respective time points. Results Mutational diversity and abundance evaluation across the 12 lineages identified 58 Recombinant sequences as harboring the least number of mutations ( n = 111), with 14 low-frequency unique mutations with major chunk of mutations coming from the BA.2. The spontaneously/dynamically increasing and decreasing trends of mutations highlight the loss of mutations in the Recombinants that were associated with the SARS-CoV-2 replication efficiency, infectivity, and disease severity, rendering them functionally with low infectivity and pathogenicity. Linkage disequilibrium (LD) analysis revealed that mutations comprising the LD blocks of BA.1, BA.2, and Recombinants were found as minor alleles or as low-frequency alleles in the LD blocks from the previous SARS-CoV-2 variant samples, especially Pre-VOC. Moreover, a dissipation in the size of LD blocks as well as LD decay along with a high negative regression coefficient (R squared) value was demonstrated in the Omicron and BA.1 and BA.2 lineages, which corroborated with the breakpoint analysis. Conclusion Together, the findings help to understand the evolution and emergence of Recombinants after the Omicron lineages, for sustenance and adaptability, to maintain the epidemic spread of SARS-CoV-2 in the host population already high in immunity levels.

The “wolf” is Indeed Coming: Recombinant “deltacron” SARS-CoV-2 Detected

The Challenge of Emerging SARS-CoV-2 Mutants to Vaccine Development

Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events

Recombinant SARS-CoV-2 Delta/Omicron BA.5 emerging in an immunocompromised long-term infected COVID-19 patient

Comprehensive detection and dissection of interlineage recombination events in the SARS-CoV-2 pandemic

The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2

Unraveling the genetic evolution of SARS-CoV-2 Recombinants using mutational dynamics across the different lineages

Genomic Feature Analysis of Betacoronavirus Provides Insights Into SARS and COVID-19 Pandemics

Identification of Various Recombinants in a Patient Coinfected With the Different SARS‐CoV‐2 Variants

In situ architecture and membrane fusion of SARS-CoV-2 Delta variant

On the Origin and Continuing Evolution of SARS-CoV-2

The Deltacron conundrum: its origin and potential health risks

Recombination-aware phylogenetic analysis sheds light on the evolutionary origin of SARS-CoV-2

The nuts and bolts of recombination in the generation of SARS-CoV-2 variants; from XA to XBB

Potential Inter‐variant and Intra‐variant Recombination of Delta and Omicron Variants

A novel SARS-CoV-2 related coronavirus with complex recombination isolated from bats in Yunnan province, China

The dominant strain of SARS-CoV-2 is a mosaicism

Untangling the Evolution of the Receptor-Binding Motif of SARS-CoV-2

Genomic Diversity and Recombination Analysis of the Spike Protein Gene from Selected Human Coronaviruses

Data-driven recombination detection in viral genomes

Characterization of a Vesicular Stomatitis Virus-Vectored Recombinant Virus Bearing Spike Protein of SARS-CoV-2 Delta Variant